Healthcare provider profile · identity verified

Whitney P Mical, FNP

Nurse Practitioner · BENNINGTON, VT · NPI 1124576475

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	252	75
Amlodipine Besylate	Amlodipine Besylate	171	50
Omeprazole	Omeprazole	167	49
Lisinopril	Lisinopril	139	41
Losartan Potassium	Losartan Potassium	105	34
Albuterol Sulfate Hfa	Albuterol Sulfate	103	26
Metoprolol Succinate	Metoprolol Succinate	99	28
Hydrochlorothiazide	Hydrochlorothiazide	79	23
Gabapentin	Gabapentin	74	24
Levothyroxine Sodium	Levothyroxine Sodium	74	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	11
Metformin Hcl Er	Metformin Hcl	64	17
Rosuvastatin Calcium	Rosuvastatin Calcium	63	20
Eliquis	Apixaban	58	18
Sertraline Hcl	Sertraline Hcl	55	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	12
Metoprolol Tartrate	Metoprolol Tartrate	51	15
Tramadol Hcl	Tramadol Hcl	51	17
Alendronate Sodium	Alendronate Sodium	49	suppressed
Simvastatin	Simvastatin	49	16
Trazodone Hcl	Trazodone Hcl	49	11
Zolpidem Tartrate	Zolpidem Tartrate	48	12
Escitalopram Oxalate	Escitalopram Oxalate	46	13
Pantoprazole Sodium	Pantoprazole Sodium	46	13
Metformin Hcl	Metformin Hcl	44	12
Ozempic	Semaglutide	44	11
Furosemide	Furosemide	38	12
Trulicity	Dulaglutide	37	suppressed
Pregabalin	Pregabalin	35	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	32	13
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Allopurinol	Allopurinol	28	11
Alprazolam	Alprazolam	28	11
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Lorazepam	Lorazepam	28	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Celecoxib	Celecoxib	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	11
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Cephalexin	Cephalexin	18	15
Famotidine	Famotidine	18	suppressed
Tiotropium Bromide	Tiotropium Bromide	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Atenolol	Atenolol	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Buspirone Hcl	Buspirone Hcl	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Amoxicillin	Amoxicillin	14	11
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error